SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCompre Grp.28 Regulatory News (RG62)

Share Price Information for Compre Grp.28 (RG62)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
RG62 Live PriceLast checked at - London Stock Exchange

Intraday Compre Grp.28 Share Chart

Compre acquires German liability portfolio

15 Aug 2022 07:00

RNS Number : 9282V
Compre Group Holdings Limited
15 August 2022
 

Press release

15 August 2022

 

 

Compre acquires German liability portfolio 

 

Compre Group Holdings Limited ("Compre"), the Bermuda headquartered, international legacy group, today announces it has acquired the hospital liability ("MedMal") portfolio of German insurer Basler Sachversicherungs-AG ("Basler"), an entity of the Baloise Group, subject to regulatory approval by the German Federal Financial Supervisory Authority ("BaFin"). Terms of the transaction are not disclosed.

 

The deal, structured as a portfolio transfer, is a further milestone for Compre, marking its ambition to build a centre of excellence for legacy MedMal business in Europe. The portfolio mainly consists of underwriting years 2004 to 2018 and as such has been in run-off for several years. The transaction, which is expected to close by year end 2022, includes the hospital liability portfolio of Basler with technical liabilities of approximately EUR200 million.

 

Subject to the relevant regulatory approvals, the portfolio will transfer in its entirety to Compre's Finnish subsidiary Bothnia International Insurance Company Ltd. Compre will work closely with Detmold-based Ecclesia Group Assekuranz Service GmbH, which will continue to provide claims support for existing customers, ensuring smooth continuity of service for policyholders.

 

In addition, Compre also recently completed a two-tranche loss portfolio transfer ("LPT") for an undisclosed European insurer, with the second tranche covering unexpired risks on a pre-determined basis. This is the first time Compre has underwritten a two-tranche LPT and is developing its pre-packaged forward LPT proposition to deliver additional future income, while providing greater certainty for its clients' future results. 

 

Will Bridger Group CEO said: "I am delighted to announce our first acquisition of pure European MedMal legacy liabilities and with a portfolio that is very well known to us. This demonstrates Compre's strong client-service focus and ability to provide highly tailored solutions to meet specific client needs."

 

Simon Hawkins CEO Europe added: "This transaction also demonstrates, after Compre recently redomiciled to Bermuda, our commitment to executing legacy deals in Europe as well as the Lloyd's and US legacy markets. While this is a new class of business for Compre, it is very much a signal of our intent to build MedMal into a significant additional area of specialisation."

 

- Ends -

For further information please contact:

Compre

David Haggie / Richard Adams / Olivia Thomson, Haggie Partners

+44 20 7562 4444

 

About Compre:

Compre is a leading legacy specialist with over 30 years of experience in the acquisition and management of discontinued and legacy non-life insurance and reinsurance business. Compre has experience of acquiring most classes of direct and reinsurance business, including general liability, marine and motor liability, and US APH. Compre has operations in Bermuda, Finland, Germany, Malta, Switzerland, UK, the US and at Lloyd's of London.

 

www.compre-group.com 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CIRUUVNRURUWAAR
Date   Source Headline
8th Jun 20263:16 pmRNSSenior Management Change
14th Apr 20269:02 amRNSCompre announces FY 2025 results
6th Feb 202612:11 pmRNSCompre Appoints David Atkins as Deputy CEO
12th Nov 20258:00 amRNSSenior Management Change
30th Sep 20257:56 amRNSInterim Financial Report - 30 June 2025
14th May 202511:17 amRNSCompre completes portfolio transfer from Ethias
17th Apr 20257:56 amRNSCompre announces FY 2024 results
16th Apr 20259:00 amRNSCompre acquires Covéa US subsidiary
13th Mar 20252:10 pmRNSCompre appoints John Howard as chairman
7th Feb 20255:00 pmRNSBoard and Senior management changes
12th Sep 20248:00 amRNSInterim Financial Report - 30 June 2024
22nd Aug 20245:19 pmRNSCompre and Accelerant execute legacy transaction
15th Aug 20247:00 amRNSCompre announces change of registered address
3rd Jun 20247:00 amRNSCompre reports record results in ‘landmark’ year
10th Jan 20249:00 amRNSCompre acquires two European liability portfolios
30th Nov 20234:37 pmRNSCompre appoints two new members to Group Board
11th Oct 20232:12 pmRNSInterim Financial Report - 30 June 2023
10th Oct 20234:55 pmRNSInterim Financial Report - 30 June 2023
4th Sep 20239:00 amRNSCompre completes acquisition of Covéa subsidiary
3rd Jul 20231:15 pmRNSSiriusPoint and Compre complete LPT transaction
22nd May 20237:40 amRNSCompre acquires workers’ comp portfolio from SUNZ
12th May 20231:45 pmRNSAudited Annual Financial Report - 31 December 2022
2nd Mar 20231:32 pmRNSCompre announces second deal with SiriusPoint
20th Oct 20227:00 amRNSCompre agrees to acquire subsidiary from Covéa
25th Aug 20228:22 amRNSCompre acquires further MedMal portfolio
15th Aug 20227:00 amRNSCompre acquires German liability portfolio

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.